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Background: Continuity of care is essential for good quality diabetes management. We recently found that 46% of
patients defaulted from care (had no contact with the clinic for 18 months after a follow-up appointment was
ordered) in a Canadian multidisciplinary tertiary care diabetes clinic. The primary aim was to compare
characteristics, diabetes processes of care, and outcomes from referral to within 1 year after leaving clinic or to the
end of the follow-up period among those patients who defaulted, were discharged or were retained in the clinic.
Methods: Retrospective cohort study of 193 patients referred to the Foustanellas Endocrine and Diabetes Center
(FEDC) for type 2 diabetes from January 1, 2005 to June 30, 2005. The FEDC is the primary academic referral centre
for the Ottawa Region and provides multidisciplinary diabetes management. Defaulters (mean age 58.5 ± 12.5 year,
60% M) were compared to patients who were retained in the clinic (mean age 61.4 ± 10.47 years, 49% M) and
those who were formally discharged (mean age 61.5 ± 13.2 years, 53.3% M). The chart audit population was then
individually linked on an individual patient basis for laboratory testing, physician visits billed through OHIP,
hospitalizations and emergency room visits using Ontario health card numbers to health administrative data from
the Ministry of Health and Long-Term Care at the Institute for Clinical and Evaluative Sciences (ICES).
Results: Retained and defaulted patients had significantly longer duration of diabetes, more microvascular
complications, were more likely to be on insulin and less likely to have a HbA1c < 7.0% than patients discharged
from clinic. A significantly lower proportion of patients who defaulted from tertiary care received recommended
monitoring for their diabetes (HbA1c measurements, lipid measurements, and periodic eye examinations), despite
no difference in median number of visits to a primary care provider (PCP). Emergency room visits were numerically
higher in the defaulters group.
Conclusions: Patients defaulting from a tertiary care diabetes hospital do not receive the recommended
monitoring for their diabetes management despite attending PCP appointments. Efforts should be made to
minimize defaulting in this group of individuals.Background
The importance of continuity of care in diabetes ma-
nagement has been well recognized. Continued attend-
ance at multidisciplinary diabetes management programs
has been shown to decrease the risk of long-term diabetes
complications [1-4], improve the uptake of preventive* Correspondence: jamalcolm@ottawahospital.on.ca
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reproduction in any medium, provided the orcare, enhance adherence to therapy, increase patient and
physician satisfaction [5] and decrease hospitalizations [6]
and emergency room visits [7-9]. Despite these benefits,
high rates of attrition and loss to follow-up have been
reported [10-12]. Defaulting from diabetes clinics may be
defined as the failure of a patient to maintain contact with
the clinic despite a scheduled follow-up appointment
made by the specialist. Defaulting from diabetes clinics is
associated with adverse outcomes including the develop-
ment of significant microvascular disease, worsening of
biochemical profile and all-cause mortality [13].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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likely significant. Patient care may be negatively im-
pacted by large numbers of patients requiring re-referral
for specialized services. Re-referral rates for defaulted
patients with diabetes to specialized care have been
reported to be as high as 20% [10]. Among elderly pa-
tients with diabetes, loss of continuity of care is associ-
ated with increased hospitalizations and emergency
room visits [6]. To date, studies on patients defaulting
from specialty diabetes clinics have focused primarily
on clinical outcomes. Understanding the health care
utilization of diabetes patients defaulting from spe-
cialty care is important in developing strategies to
improve continuity of care for patients with type 2 dia-
betes (DM2).
A local audit of our tertiary care multidisciplinary
clinic indicated that 23% of patients referred by primary
care providers for diabetes care were discharged back to
primary care, while 46% of patients defaulted from clinic
[14]. We suspect that the extent of defaulting observed
in our centre may be reflective of other tertiary care dia-
betes clinics.
In this paper, we describe the characteristics, long-
term outcomes, and health care utilization of patients
who defaulted from clinic and compare them to those
who were retained or were discharged back to the care
of their primary care provider.
Methods
The Foustanellas Endocrine and Diabetes Centre (FEDC)
in Ottawa, Canada is the academic referral centre for the
Ottawa region. It serves a catchment area of over one
million people and provides specialized interdisciplinary
clinical management, education and self-management
support for diabetes. There are approximately 20,000 pa-
tient visits per year, of which 20% are new referrals.
A chart audit was conducted at the FEDC by an endo-
crinology fellow and a diabetes nurse specialist. The first
10 charts were reviewed independently by both auditors
and the results compared. A data collection guide was
developed based on discrepancies between the two audi-
tors. The remainder of the charts was divided between
the two auditors and data were entered electronically
into the database using the data collection guide. The
auditors met on a regular basis to review items for which
interpretation remained unclear after using the data col-
lection guide.
The chart audit population was then individually
linked using Ontario health card numbers to health ad-
ministrative data from the Ministry of Health and Long-
Term Care housed at the Institute for Clinical and
Evaluative Sciences (ICES). Because of the single-payer
universal health care system in Ontario, these data de-
scribe all care received by Ontario residents with nomissing data or loss to follow-up. The databases used in
this study included: the Registered Persons Database,
which records health care eligibility and demographic in-
formation such as date of death; the discharge abstract
database for hospital admission information occurring
after the date of final recorded visit with the FEDC dur-
ing the review period; the National Ambulatory Care
Reporting System for emergency department visits oc-
curring after the last recorded visit with the FEDC dur-
ing the review period; the physician service claims
database for family doctor and specialist visits, labora-
tory tests and renal replacement therapy; and the ICES
Physicians Database for location and type of physician
practice.
Laboratory investigations done at the Ottawa Hospital
were in the OACIS Ottawa Hospital Database. This
database was searched by the investigators for all perti-
nent laboratory results done in the follow-up period for
all three groups.
All patients who were first seen by an endocrinologist
for management of DM2 between January 1 and June
30, 2005 were included in a retrospective chart review.
Of the 923 referred diabetes patients, 226 were exclu-
ded due to a clear diagnosis of type 1 diabetes (DM1). A
computer-generated, uniform random number was as-
signed to the remaining 697 patients who were then
assessed for eligibility in random sequence until the
targeted sample size of 200 was reached. The sample size
of 200 was chosen to allow a two-sided 95% Confidence
Interval (CI) for a single proportion (e.g., the proportion
of patients discharged from the clinic), using the large
sample normal approximation, to extend 7.1% from the
most conservative proportion of 50%, while allowing for
a 5% patient exclusion rate.
Data collected in the FEDC chart review included:
demographics, past medical history, medication use, pro-
cesses of care indicators, outcome of care indicators,
number of visits to each diabetes team member (physi-
cian, nurse, dietician, social worker), and current status
with FEDC (discharged back to PCP, retained, or de-
faulted). Defaulting was defined as no contact with the
clinic for 18 months after a follow-up appointment was
ordered by the specialist. Data collection continued until
the patient was discharged or had defaulted or until the
end of the follow-up period in October 2008, whichever
came first.
Individuals were then linked between databases and
across time via their Ontario health card number, ano-
nymized using a reproducible encryption algorithm.
Processes of care indicators (percent receiving A1c
measurements, lipid profiles, serum creatinine, annual
eye examination), health care utilization (mean visits
to primary care physician) and outcomes (emergency
room visits and hospital admissions) were collected.
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information was compared among the three groups. The
proportions of patients meeting the 2003 Canadian Dia-
betes Association (CDA) recommended targets (CDA
guidelines) for glycated hemoglobin (A1C ≤ 7%, LDL
cholesterol <2.5 mmol/L, and blood pressure ≤ 130/80
were calculated ; the proportions of patients meeting
one, two or all three targets were compared among the
groups. This study was developed prior to the publi-
cation of the 2013 CDA guidelines, at which point some
of the targets changed. The 2003 guidelines differ from
the 2013 guidelines in a few minor areas. The glycated
hemoglobin target remained ≤ 7% for most patients with
type 1 and type 2 diabetes; however the 2013 guidelines
allow for greater individualization of targets for patients
based on their age, duration of diabetes, risk of severe
hypoglycaemia, life expectancy, and presence cardio-
vascular disease. The LDL-cholesterol target has drop-
ped to <2.0 mmol/L based on evidence from a number
of large randomized controlled trials published after
2003. The blood pressure targets remained the same. As
these changes were minor, the difference in guidelines
from 2003 to 2013 does not have a significant effect the
interpretation of the results.
This study was approved by the Ottawa Hospital Re-
search Ethics Board.
Statistical analysis
Using chart review data, the demographic characteristics
and first and last visit outcomes of the patient cohort
were summarized for defaulters retained and discharged
groups. Frequencies and percentages were calculated for
categorical variables, means and standard deviations
for continuous variables, and medians and interquartile
ranges (IQR) for ordinal variables or variables with
skewed distributions. Differences in process and clinical
outcome measures among the three groups (retained,
discharged, and defaulted) were tested for statistical sig-
nificance using 1-way analysis of variance in the case of
continuous variables, chi-squared tests or Fisher’s exact
tests for categorical variables, and Kruskal-Wallis tests
for ordinal variables or variables with skewed distribu-
tions. Because we recognize that multiple testing can
lead to spurious statistical significance, we considered all
these tests as exploratory. If the overall test among the
three groups was significant at α = 0.15, we proceeded to
conduct pairwise tests to further delineate differences
between the groups. To maintain the familywise er-
ror rate of the pairwise comparisons, the Bonferroni-
corrected significance level of α = 0.017 was used for
these pairwise comparisons. It was expected that some
proportion of the items would be incomplete in this
chart review. For example, we only recorded retinopathy
as present or absent if a test for retinopathy had beenindicated in the chart; if no test result were available,
this item was recorded as missing. No imputation for
missing items was planned; each analysis was based
on subjects with non-missing values for the relevant
variables.
Using the linked health administrative data, dichoto-
mous process of care, and outcomes of defaulters, the
retained and discharged groups were described using
point estimates with 95% confidence intervals for pro-
portions using the normal approximation to the bino-
mial distribution, or the exact binomial method in the
case of small frequencies.
Outcomes summarized as counts (e.g., number of vi-
sits with primary care providers, or number of HbA1C
measurements) were described as annual rates, together
with 95% Poisson confidence intervals using exact
methods or using the normal approximation with con-
tinuity correction.
The statistical significance of differences in process of
care, and proximal and distal outcomes among the three
patient groups were assessed using chi-squared tests for
dichotomous variables and one-way analysis of variance
for continuous variables.
All analyses were conducted using SAS version 9.1
(Cary, NC).
Results
Of the original 200 patients, one chart was noted to be
entered twice during statistical analysis and was ex-
cluded. Of the remaining 199 patients, 2 patients had
died and 4 were transferred to another institution. These
patients, making up only 3.1% of the total cohort, are
not included in further description and analysis. The
characteristics of the remaining 193 patients at their first
visit to the FEDC are presented in Table 1. Referred pa-
tients had a median duration of diabetes of 6 years (IQR
1–12), and lived primarily in an urban setting (90.2%).
Macrovascular complications were present in 51 pa-
tients (28.3%) and 79 patients (40.9%) had microvas-
cular complications.
Of the 193 patients, 29.6% (95% CI 24.1%-37.1%) were
retained in clinic (after a median duration of follow-up of
33 months), 23.1% (95% CI 17.8%-29.9%) were discharged
(after a median duration of follow-up of 10 months), and
44.2% (95% CI 38.6%-52.6%) defaulted (after a median
duration of follow-up of 9 months).
When these 3 groups were examined retrospectively
to their first visit at the FEDC (see Table 1), duration
of diabetes, proportion of re-referrals, proportion of
patients with any microvascular disease, neuropathy, in-
sulin use, and HbA1c ≤7% (53 mmol/mol), were signifi-
cantly different among the three groups based on the
overall test of significance. Based on the pairwise com-
parisons, the retained group had longer duration of
Table 1 Comparison of first visit characteristics among patients retained, discharged, and defaulted
First visit characteristics Overall
(N = 193)
Retained
(R) (N = 59)
Discharged
(D/C) (N = 46)
Defaulted









Age (mean, SD) 59.1 (12.3) 59.1 (9.9) 60.6 (14) 58.3 (12.9) 0.5944
Male (%) 106 (54.9) 28 (47.5) 25 (54.4) 53 (60.2) 0.3112
Distance from clinic (km)(median, IQR) 12.4 (7.4–20.5) 14.2 (7.9–20.7) 13.4 (7.2–17.8) 10.7 (7.5–23.9) 0.7194
Urban (%) 174 (90.2) 51 (86.4) 45 (97.8) 78 (88.6) 0.1227 0.0741 0.6906 0.0967
Number of re-referrals (%) 36 (18.8) 14 (24.1%) 3 (6.5%) 19 (21.6%) 0.0477 0.0158 0.7188 0.0254
Medical history
Duration DM2 (years) – (median, IQR) 6 (1–12) 8 (2–15) 2.5 (1–8.5) 7 (2.5–12) 0.0187 0.0146 0.7622 0.0114
Hypertension (%) 142 (74) 44 (74.6) 34 (75.6) 64 (72.7) 0.9321
Dyslipidemia (%) 154 (83.7) 49 (86.0) 36 (83.7) 69 (82.1) 0.8338
Psychiatric disease (%) 41 (21.9) 16 (27.6) 7 (15.6) 18 (21.4) 0.3388
Macrovascular complications
CAD (%) 41 (22.5) 16 (28.6) 8 (18.2) 17 (20.7) 0.4066
PVD (%) 11 (6.0) 5 (8.5) 1 (2.3) 5 (6.1) 0.5275
CVA/TIA (%) 10 (5.3) 6 (10.2) 0 4 (4.7) 0.0719 0.0380 0.3170 0.3005
Any macrovascular complications (%) 51 (28.3) 21 (36.8) 8 (18.6) 22 (27.5) 0.1311 0.0466 0.2455 0.2733
Microvascular complications
Nephropathy (%) 49 (27.1) 18 (31.6) 9 (20.9) 22 (27.2) 0.4945
Retinopathy (%) 26 (17.6) 12 (23.5) 2 (5.9) 12 (19.1) 0.1026 0.0316 0.5595 0.1281
Neuropathy (%) 49 (26.9) 13 (22.4) 7 (16.3) 29 (35.8) 0.0424 0.4443 0.0901 0.0226
Any microvascular complications (%) 79 (40.9) 24 (47.1) 13 (33.3) 42 (59.2) 0.0328 0.1897 0.1860 0.0096
Disease status
HbA1c (%)(mean, SD) 8.5 (1.9) 8.6 (1.8) 7.9 (1.9) 8.7 (1.9) 0.0609 0.0669 0.6694 0.0243
HbA1c (IFCC units mmol/mol) 69 70 63 72
HbA1c ≤7.0% or 53 mmol/mol (%) 47 (25.5) 16 (27.6) 17 (39.5) 14 (16.9) 0.0199 0.2055 0.1259 0.0051
Weight (kg) (mean, SD) 94.1 (23.2) 93.0 (22.3) 88.9 (18.9) 97.6 (25.3) 0.1122 0.3252 0.2608 0.0448
BMI (mean, SD) 33.8 (7.7) 33.8 (7.8) 32.5(6.3) 34.5 (8.2) 0.3738
SBP (mean, SD) 140.9 (20.0) 141.2 (23.2) 138.7 (19.3) 141.8 (18.0) 0.6879
DBP (mean, SD) 75.1 (10.0) 75.5 (11.1) 75.4 (9.4) 74.6 (9.5) 0.8267
Total Cholesterol (mean, SD) 4.99 (1.41) 4.96 (1.44) 4.98 (1.1) 5.02 (1.55) 0.9694
HDL-C (mean, SD) 1.19 (0.33) 1.22 (0.32) 1.21 (0.33) 1.15 (0.33) 0.5015
LDL-C (mean, SD) 2.65 (1.01) 2.64 (1.04) 2.85 (1.03) 2.53 (0.97) 0.3139
Triglycerides (median, IQR) 2.06 (1.5–2.92) 1.92 (1.39–2.99) 2.12 (1.58–2.59) 2.18 (1.5–2.99) 0.8033
TC:HDL-C (mean, SD) 4.33 (1.41) 4.19 (1.27) 4.35 (1.27) 4.43 (1.59) 0.6311
Smoker (%) 37 (20.1%) 8 (13.8) 7 (16.3) 22 (26.5) 0.1390 0.7283 0.0695 0.1960
First visit medications
On Insulin (%) 47 (24.4%) 23 (39.0) 3 (6.5) 21 (23.9) 0.0006 0.0001 0.0498 0.0129
On ACE-I/ARB (%) 114 (59.7) 44 (74.6) 25 (54.4) 45 (52.3) 0.0191 0.0303 0.0069 0.8245
On ASA (%) 76 (39.8) 26 (44.1) 16 (35.6) 34 (39.1) 0.6684
On Statin (%) 98 (50.8) 34 (57.6) 23 (50.0) 41 (46.6) 0.4198
Note: p-values significant at 5%, with Bonferroni adjustment for pairwise comparisons, are printed in bold type. R Retained, D/C Discharged, DF Defaulted,
CAD Coronary artery disease, PVD Peripheral vascular disease, CVA Cerebral vascular accident, TIA Transient ischemic attack, HbA1c Glycated hemoglobin,
kg kilograms, BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, HDL-C High-density lipoprotein-cholesterol, TC:HDL-C Total
cholesterol to HDL-cholesterol ratio, LDL-C Low-density lipoprotein-cholesterol, ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker
(antagonist), ASA Acetylsalicylic acid, MD Medical doctor, RN Registered nurse, RD Registered dietitian, SD Standard deviation, IQR Interquartile range.
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likely to be on insulin at baseline than the discharged
group. Patients who had defaulted had longer duration
of DM2, were more likely to have microvascular compli-
cations, were less likely to have HbA1c ≤7% and were
more likely to be on insulin at baseline than those
discharged. No difference was noted in mean distance
travelled to the clinic or proportion living in an urban
setting between groups.
A comparison of characteristics of the 3 groups at the
last visit is presented in Table 2. Significant differences
among the groups were found for the proportions of pa-
tients with any microvascular complications, retinop-
athy, and HbA1c ≤7%. The proportions of patients on
insulin and acetylsalicylic acid (ASA) at last visit were
also significantly different among the groups with the
highest proportion on these medications in the retained
group. Based on the pairwise comparisons, patients who
defaulted were more likely to be on insulin and less
likely to have HbA1c ≤7% at last visit than discharged
patients. Compared with those retained in the clinic,
defaulted patients were less likely to be on insulin or
ASA at last visit. No significant differences among
the groups were noted for macrovascular complica-
tions, blood pressure, smoking status, LDL-C, use of
angiotensin-converting enzyme inhibitor (ACE-I), angio-
tensin receptor blocker antagonist (ARB) and use of
statins.
Significant differences were noted for indicators of
clinic activity (Table 2). The mean percentage of visits
where medications were changed by the physician was
lowest in the discharged group (34.4% versus 55.2% in
the retained group and 51.8% in the defaulted group, p
= 0.0007). The median percentage of missed appoint-
ments that were no-shows was highest in the defaulted
group (30% versus 8.3% in the retained group and 0% in
the discharged group, p < 0.0001).
The percentages of patients meeting 2003 CDA Guide-
line recommended targets for HbA1c, LDL-C and BP at
their last clinic visit are presented in Figure 1. The
defaulted group had the lowest proportion of patients
meeting all three targets at 4.8%. Of the patients who
attained treatment targets for LDL-C and HbA1c,
retained patients were more likely to be on insulin at
their last clinic appointment (44.4%) than those dis-
charged (12.0%) or defaulted (7.7%) but these differences
were not statistically significant at the Bonferroni-
corrected levels. There were no statistically significant
differences in microvascular or macrovascular complica-
tions among groups in patients who had reached 2 or 3
targets at their last clinic visit.
Long-term outcomes of our cohort were available for
179 patients (Table 3). Patients without Ontario Health
Card Numbers (e.g., residents of the neighbouringprovince of Quebec) (N = 14) were excluded from this
analysis. A significantly lower proportion of patients
who defaulted from tertiary care received recommended
monitoring for their diabetes (HbA1c measurements,
lipid measurements, and periodic eye examinations),
despite no difference in mean number of visits to a pri-
mary care provider (PCP). The proportion of patients
with emergency room visits was numerically higher in
the defaulters group.
Discussion
We found almost half of the patients referred to the
clinic (44.2%) defaulted from care, while 23.1% were
discharged and 29.6% of patients were retained in clinic.
Patients in the defaulted group had the lowest propor-
tion reaching CDA treatment targets for HbA1c, LDL-C,
and BP while attending diabetes clinic. One year after
the last documented clinic appointment, the defaulted
patient group also had the lowest proportion receiving
A1C measurements, lipid profile measurements and eye
examinations despite having a similar mean number of
visits to primary care physicians as the discharged and
retained patients groups. A possible explanation is pri-
mary care physicians may have been unaware that the
patient had stopped attending diabetes clinic visits and
were therefore not ordering diabetes monitoring in-
vestigations. Patients may also have perceived their dia-
betes as “less important” relative to their other medical
problems and therefore did not follow through with
recommended monitoring or the follow up with the dia-
betes clinic.
The long-term consequences of defaulting from a dia-
betes clinic such as worsened glucose control, increased
BP, increased prevalence of complications, and increased
all cause mortality have been reported [13]. Currie et al.
have demonstrated a “dose –response” relationship with
those having >2 missed appointments being at signifi-
cantly higher risk of all cause mortality. Decreased mon-
itoring may increase the need for emergency treatment
of acute decompensations. The proportion of patients
with emergency room visits was numerically higher in
our cohort. Access to specialty care may be negatively
impacted if these patients require re-referral to already
overstretched diabetes resources. Identification of pa-
tients at risk of defaulting is necessary to both prevent
negative impact on the health care system and possibly
prevent adverse outcomes for patients. One finding that
may signal a patient at risk of defaulting is failure to
keep appointments [12,15]. Consistent with other groups,
we also observed that the no-show rate was highest in the
defaulted population.
The high proportion of patients defaulting from care
was initially surprising to us. This rate is, however, simi-
lar to other reports [16]. The prevalence of defaulting
Table 2 Comparison of last visit characteristics among patients retained, discharged, and defaulted
Last visit characteristics Overall
(N = 193)
Retained
(R) (N = 59)
Discharged
(D/C) (N = 46)
Defaulted










CAD (%) 45 (23.8) 17 (29.3) 9 (20.0) 19 (22.1) 0.4802
PVD (%) 14 (7.5) 6 (10.2) 1 (2.3) 7 (8.2) 0.3081
CVA/TIA (%) 12 (6.3) 7 (12.1) 1 (2.2) 4 (4.6) 0.1305 0.1336 0.1164 0.4980
Any macrovascular complications (%) 57 (30.0) 23 (39.0) 10 (22.2) 24 (27.9) 0.1539
Microvascular complications
Nephropathy (%) 65 (35.7) 24 (40.7) 11 (25.6) 30 (37.5) 0.2635
Retinopathy (%) 31 (18.8) 14 (25.6) 2 (5.1) 15 (21.7) 0.0406 0.0121 0.7080 0.0228
Neuropathy (%) 50 (27.3) 15 (25.9) 7 (15.9) 28 (34.6) 0.0785 0.2261 0.2735 0.0265
Any microvascular complications (%) 95 (53.7) 31 (53.5) 16 (37.2) 48 (63.2) 0.0243 0.1057 0.2576 0.0064
Disease status (last visit):
HbA1c (%)(mean, SD) 7.6 (1.6) 7.8 (1.8) 6.6 (0.9) 7.9 (1.5) <0.0001 <0.0001 0.7069 <0.0001
HbA1c (IFCC units mmol/mol) 60 62 49 63
HbA1c≤ 7.0% or 53 mmol/mol (%) 86 (46.2) 25 (42.4) 37 (84.1) 24 (28.9) <0.0001 <0.0001 0.0964 <0.0001
Change in HbA1c (%) (mean, SD) −0.90 (1.7) −0.74 (1.75) −1.28 (1.87) −0.80 (1.69) 0.2480
Weight (kg) (mean, SD) 94.5 (23.3) 94.3 (21.8) 88.8 (21.2) 97.6 (25.0) 0.1289 0.2074 0.4183 0.0495
Change in weight (mean, SD) 0.8 (5.1) 1.6 (5.6) 0.3 (5.3) 0.4 (4.7) 0.2978
BMI 33.9 (7.7) 34.2 (7.4) 32.5 (7.2) 34.5 (8.2) 0.3726
SBP (mean, SD) 139.2 (19.8) 141.7 (21.8) 133.4 (17.9) 140.5 (18.9) 0.0712 0.0390 0.7263 0.0376
DBP (mean, SD) 73.1 (9.6) 71.8 (9.6) 72.4 (10.4) 74.2 (9.1) 0.2828
Total Chol (mean, SD) 4.5 (1.4) 4.4 (1.2) 4.4 (1.1) 4.7 (1.6) 0.2377
HDL-C (mean, SD) 1.2 (0.3) 1.1 (0.3) 1.2 (0.3) 1.2 (0.3) 0.6053
LDL-C (mean, SD) 2.3 (1.0) 2.4(1.0) 2.3 (1.0) 2.3 (1.0) 0.8984
Triglycerides (median, QR) 1.8 (1.2–2.7) 1.7 (1.3–2.5) 1.8 (1.2–2.5) 1.9 (1.3–3.2) 0.3467
TC:HDL-C (mean, SD) 4.1 (1.4) 4.03 (1.2) 3.82 (1.2) 4.31 (1.6) 0.1874
Smoker (%) 33 (18.8) 6 (10.9) 7 (16.3) 20 (25.6) 0.0897 0.4367 0.0349 0.2365
Last visit medications:
On insulin (%) 75 (38.9) 37 (62.7) 7 (15.2) 31 (35.2) <0.0001 <0.0001 0.0011 0.0147
On ACE-I/ARB (%) 144 (74.6) 48 (81.4) 33 (71.7) 63 (71.6) 0.3604
On ASA (%) 94 (48.7) 37 (62.7) 20 (43.5) 37 (42.1) 0.0351 0.0497 0.0140 0.8734
On Statin (%) 146 (75.7) 49 (83.1) 37 (80.4) 60 (68.2) 0.0825 0.7297 0.0436 0.1320
Clinic activity
Median duration of follow-up (months) 16 (6 to 31) 33(31 to 35) 10 (4 to 18) 9 (5 to 17) <0.0001 <0.0001 <0.0001 0.8827
% of MD visits where meds changed
(Mean, SD)
48.7 (30.0) 55.2 (23.1) 34.4 (25.7) 51.8 (33.9) 0.0007 <0.0001 0.5037 0.0027
% of patient encounters that were
no-shows (Median, IQR)
14.3 (0 to 33.3) 8.3 (0 to 16.7) 0 (0 to 14.3) 30 (13.8 to 50.0) <0.0001 0.1112 <0.0001 <0.0001
Number of visits with MD (mean, SD) 4.9 (3.1) 8.1 (2.8) 3.3 (1.9) 3.7 (2.0) <0.0001 <0.0001 <0.0001 0.2907
Number of visits with RN (mean, SD) 2.5 (2.1) 3.7 (2.6) 2.1 (1.7) 2.0 (1.7) <0.0001 0.0006 <0.0001 0.6919
Number of visits with RD (mean, SD) 2.4 (2.0) 3.5 (2.5) 2.2 (1.9) 1.7 (1.3) <0.0001 0.0036 <0.0001 0.1053
Note: p-values significant at 5%, with Bonferroni adjustment for pairwise comparisons, are printed in bold type, R Retained, D/C Discharged, DF Defaulted, CAD
Coronary artery disease, PVD Peripheral vascular disease, CVA Cerebral vascular accident, TIA Transient ischemic attack, HbA1c Glycated hemoglobin, kg kilograms,
BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, HDL-C High-density lipoprotein-cholesterol, TC:HDL-C Total cholesterol to
HDL-cholesterol ratio, LDL-C Low-density lipoprotein-cholesterol, ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker (antagonist),
ASA Acetylsalicylic acid, MD Medical doctor, RN Registered nurse, RD Registered dietitian, SD Standard deviation, IQR Interquartile range.








HbA1C only 84.09 42.37 28.92 
HbA1c & LDL-C 62.5 31.58 17.11 
HbA1c & BP 30.2 13.6 8.5 
All 3 27.91 10.34 4.76 
Discharged Retained Defaulted
Figure 1 Percentage of patients in each group achieving 2003
Canadian Diabetes Association recommended targets for
HbA1c, LDL-C and BP.
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[10,17-19], 12-50% in the United States [11,20], and 35-
57% in Japan [4,21]. In Canada, there are little data on
defaulting rates. Shah et al. [22] reported that among pa-
tients referred to endocrinologists at 4 Canadian teaching
hospitals, 23.5% did not return for a follow-up visit after
an initial visit with the endocrinologist.
Our review was not designed to identify reasons for
defaulting; however, we have identified some trends. De-
faulters had a numerically higher mean weight, and the
highest proportion of smokers. These findings were
similar to those of Graber et al. [11] and Currie et al.
[13], who found that the proportion of smokers was sig-
nificantly higher in patients who missed clinic appoint-
ments. This finding may be due in part to the challenges
patients who default from specialty care face in the man-
agement of their disease. These patients are less likely to
participate in self-care, are more likely to have denial
concerning their disease and are likely less engaged and
empowered in the management of their disease. It isTable 3 Comparison of process-of-care indicators and outcom
Variable Retained N = 51
Mean A1c measurements received (sd) 1.92 (1.31)
Received A1C (%) 46 (90.2)
Received lipid profile (%) 46 (90.2)
Received eye exam (%) 41 (80.4)
Received Creatinine (%) 45 (88.2)
Mean visits to primary care (sd) 8 (7)
Received annual physical exam (%) 9 (17.6)
Proportion with an emergency room visit (%) 13 (25.5)
Proportion admitted to hospital (%) 9 (17.6)therefore not surprising that we observed that the de-
faulters group had the lowest proportion of patients
meeting targets for HbA1c, BP, or LDL-C during the
time they were followed in the diabetes clinic and were
more likely to be on insulin than discharged patients.
They had a similar percentage of visits where medica-
tions were changed by the attending physician to that of
patients in the retained group [52% vs. 55%] suggesting
unstable disease. These findings suggest that defaulters
from our clinic had the most poorly controlled disease
and should have had continued follow-up.
In contrast to our findings, Masuda et al. found de-
faulters were younger, less likely to be on medications,
had shorter duration of diabetes, and lower HbA1c
levels [23]. The authors concluded that these patients
with “milder” disease may have been discharging them-
selves from clinic due to the belief that their disease
was not severe enough to warrant intensive therapy.
Simmons et al. and Currie et al. had similar results
[13,24]. The differences between our population of de-
faulters and defaulters described by others likely reflect
the referral pattern of our region in which the more
complex patients with advanced disease are referred to
tertiary care while patients with milder disease are cared
for in the community. This finding may be similar to
other communities with a similar referral structure.
It is also interesting to note that despite poor glycemic
control, the percentage of patients on insulin at last visit
with the FEDC was significantly lower in the defaulted
group compared to the retained group. Some patients
possibly chose not to return to clinic when insulin ther-
apy was proposed. It is likely that patients who fail to
achieve control because of inadequate adherence to be-
havioural change or medications are also likely to be
inadherent with attending clinic [25].
The primary limitation of this study is the inherent na-
ture of a chart audit. Patient records may be incomplete
reflections of the care encounter. Lack of standardi-
zation in chart formats, variations in professional re-
cording practices and legibility are also concerns [26].es 1 year after study end
Discharged N = 45 Defaulted N = 83 P-value
1.58 (1.32) 1.37 (1.15) 0.055
33 (73.3) 56 (67.5) 0.011
35 (77.8) 54 (65.1) 0.004
27 (60.0) 44 (53.0) 0.006
37 (82.2) 62 (74.7) 0.15
6.5 (5) 6.4 (6) 0.319
7 (15.6) 10 (12) 0.654
10 (22.2) 33 (39.8) 0.071
6 (13.3) 18 (21.7) 0.501
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http://www.biomedcentral.com/1472-6963/13/303Although we did not have the resources to conduct
double extraction of the data, measures were taken to
ensure inter-rater reliability. A data extraction guide was
created and frequent meetings between auditors were
held to minimize problems in interpretation of data
recorded. Our analyses excluded patients with missing
values, and to the extent that patients with missing
values are significantly different from those included in
the analysis, our comparisons may be biased.
Conclusions
In our review of patients referred to an interdisciplinary
clinic with DM2, we found a low discharge rate but a
much higher than anticipated proportion of patients
who defaulted from clinic. Patients who defaulted from
clinic had the most uncontrolled disease and did not re-
ceive recommended monitoring of their diabetes after
leaving the diabetes clinic despite continued visits to pri-
mary care. No show rates were highest in the defaulting
population and could signal patients at risk of defaulting.
Further study into the reasons, long-term consequences
and strategies to prevent defaulting is required to ensure
that this population receives the care they need.
Competing interests
The authors declare they have no competing interests.
Authors’ contributions
JCM conceived of the study, participated in study design, interpretation of
data, and drafted the manuscript. JM conceived of the study, participated in
study design, interpretation of data, data collection, and drafted the
manuscript. BS participated in study design and performed statistical analysis.
MT participated in study design and performed statistical analysis. EK
participated in study design and interpretation of data. CT participated in
study design, interpretation of data, data collection and helped to draft the
manuscript. TO conceived of the study, participated in study design,
interpretation of data and helped to draft the manuscript. CL participated in
study design and was involved revising the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
Unrestricted grants received from Novo Nordisk Canada Inc., LifeScan
Canada Ltd., Merck Frosst Canada Ltd., Schering-Plough Canada Inc. and
Merck Frosst/Schering Pharmaceuticals were used to fund this research.
All phases of this study, including design, data collection, analysis and
interpretation, report writing and decision to submit this article for
publication were undertaken by the authors, independently from
any funders.
Author details
1Department of Medicine, University of Ottawa, Ottawa, ON, Canada. 2The
Ottawa Hospital Research Institute, Ottawa, ON, Canada. 3Clinical
Epidemiology Program, Ottawa Hospital Research institute, Ottawa, ON,
Canada. 4Department of Epidemiology and Community Medicine, University
of Ottawa, Ottawa, ON, Canada. 5Department of Medicine, University of
Toronto, Toronto, Canada. 6Department of Medicine, Sunnybrook Health
Sciences Centre, Toronto, ON, Canada. 7Bruyere Research Institute, Ottawa,
ON, Canada. 8Department of Family Medicine, University of Ottawa, Ottawa,
ON, Canada. 9The Ottawa Hospital, Ottawa, ON, Canada. 10Institute for
Clinical Evaluative Sciences, Toronto, ON, Canada.
Received: 11 February 2013 Accepted: 8 August 2013
Published: 10 August 2013References
1. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR: 10-Year follow-up
of intensive glucose control in type 2 diabetes. New England Journal of
Medicine 2008, 359:1577–1589.
2. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pederson O:
Multifactorial intervention and cardiovascular disease in patients
with type 2 diabetes. New England Journal of Medicine 2003,
348:383–393.
3. Gaede P, Lund-Andersen H, Parving HH, Pederson O: Effect of a
multifactorial intervention on mortality in type 2 diabetes. New England
Journal of Medicine 2008, 358:580–591.
4. Sone H, Kawai K, Takagi H, Yamada N, Kobayashi M: Outcome of one-year
of specialist care of patients with type 2 diabetes: a multi-center
prospective survey. Intern Med 2006, 45:589–597.
5. Gray DP, Evans P, Sweeney K, Lings P, Seamark D, Dixon M, Bradley N:
Towards a theory of continuity of care. Journal of Research of Social
Medicine 2003, 96:160–166.
6. Knight J, Dowden JJ, Worrall GJ, Gadag VG, Murphy MM: Does higher
continuity of family physician care reduce hospitalizations in elderly
people with diabetes? Popul Health Manag 2009, 12:81–86.
7. Gill JM, Mainous AG, Nsereko M: The effect of continuity of care on
emergency department use. Arch Fam Med 2000, 9:333–338.
8. Ionescu-Ittu R, McCusker J, Ciampi A, Vadeboncour AM, Roberge D,
Larouche D, Verdon J, Pineault R: Continuity of primary care and
emergency department utilization among elderly people. CMAJ 2007,
177:1362–1368.
9. McCusker J, Tousignant P, Borges Da Silva R, Ciampi A, Levesque JF,
Vadeboncoeur A, Sanche S: Factors predicting patient use of the
emergency department: a retrospective cohort study. CMAJ 2012,
184:E307–E316.
10. Archibald LK, Gill GV: Diabetic clinic defaulters – Who are they and why
do they default? Practical Diabetes 1992, 9(1):13–14.
11. Graber AL, Davidson P, Brown AW, McRae JR, Woolridge K: Dropout and
relapse during diabetes care. Diabetes Care 1992, 15:1477–1483.
12. Karter AJ, Parker MM, Moffett HH, Ahmed AT, Ferrara A, Liu JY, Selby JV:
Missed appointments and poor glycemic control: an opportunity to
identify high-risk diabetic patients. Med Care 2004, 42:110–115.
13. Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton
C, Evans M: The impact of treatment noncompliance on mortality in
people with Type 2 Diabetes. Diabetes Care 2012, 35:1279–1284.
14. Tailor C, Malcolm J, Maranger J, Keely E, Brez S, Izzi S, Taljaard M, Ooi TC:
He tools for transition program: characteristics and disposition of
patients referred to a multi-disciplinary diabetes clinic. Canadian Journal
of Diabetes 2008, 32(1):27.
15. Lee V, Earnest A, Chen M, Krishnan B: Predictors of failed attendance in a
multi-specialty outpatient centre using electronic databases. BMC Health
Serv Res 2005, 5:1–8.
16. Gucciardi E: A systematic review of attrition from diabetes education
services: strategies to improve attrition and retention research.
Can J Diabetes 2008, 32:53–65.
17. Lloyd J, Sherriff R, Fisher M, Burns-Cox C: Non-attendance at the diabetes
clinic. Practical Diabetes 1990, 7:228–229.
18. Hammersley MS, Holland MR, Walford S, Thorn PA: What happens to
defaulters from a diabetes clinic? Br Med J 1985, 291:1330–1332.
19. Scobie I, Rafferty A, Franks P, Sonksen H: Why patients were lost to
follow-up from an urban diabetic clinic. Br Med J 1983, 286:189–190.
20. Benoit S, Ji M, Flemming R, Philis-Tsimikas A: Predictors of dropouts from a
San Diego diabetes program: a case control study. Prev Chronic Dis 2004,
1:1–8.
21. Kawahara R, Amemiya T, Yoshino M, Miyamae M, Sasamoto K: Dropout of
young non-insulin-dependent diabetics from diabetes care. Diabetes Res
Clin Pract 1994, 24:181–185.
22. Shah B, James J, Lawton C, Montada-Atin T, Sigmon M, Cauch-Dudek K,
Booth G: Diabetes quality of care in academic endocrinology practice: a
descriptive study. Can J Diabetes 2009, 33:150–155.
23. Masuda YA, Kubo A, Kokaze A, Yoshida M, Sekiguchi K, Fukuhara N,
Takashima Y: Personal features and dropout from diabetes care. Environ
Health Prev Med 2006, 11:115–119.
24. Simmons D, Flemming C: Prevalence and charactersitics of diabetic
patients with no ongoing care in South Aukland. Diabtes Care 2000,
23:1791–1793.
Malcolm et al. BMC Health Services Research 2013, 13:303 Page 9 of 9
http://www.biomedcentral.com/1472-6963/13/30325. Rhee M, Slocum W, Zeimer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL,
Barnes C, Phillips LS: Patient adherence improves glycemic control.
Diabetes Educ 2005, 31:240–250.
26. Jennett P, Affleck L: Chart audit and chart simulated recall as methods of
needs assessment in continuing professional health education. JCEHP
1998, 18:163–171.
doi:10.1186/1472-6963-13-303
Cite this article as: Malcolm et al.: Into the abyss: diabetes process of
care indicators and outcomes of defaulters from a Canadian tertiary
care multidisciplinary diabetes clinic. BMC Health Services Research
2013 13:303.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
